Edgewise Therapeutics begins Phase II Becker Muscular Dystrophy trial
The trial is expected to recruit around 66 subjects at up to 14 sites in the UK, US and the…
Netherlands
Latest in
Netherlands
Akston doses first subjects in Phase II Covid-19 booster trial
Being carried out at the UMCG in the Netherlands, the trial will enrol healthy adult subjects aged between 18 and…
Akston to launch Phase II trial of Covid-19 booster vaccine in Netherlands
The trial will assess the immune system’s response to a 90µg booster dose of the AKS-452 vaccine in 600 subjects.
NewAmsterdam Pharma reports positive data in Phase II dyslipidemia trial
In the trial, treatment with 5mg and 10mg obicetrapib respectively led to a 42% and 51% decline in LDL-c.
Triall enters partnership to anchor Covid-19 data to blockchain
Triall will leverage LTO Network's blockchain technology and infrastructure to anchor the research data.
Akston initiates subject dosing in Phase II Covid-19 vaccine trial
Being carried out at University Medical Center Groningen in the Netherlands, the trial will have 52 participants.
argenx reports positive data of efgartigimod in myasthenia gravis trial
The Phase III trial met the primary endpoint with efgartigimod showing improvement in the quality of life of patients.
AIM ImmunoTech initiates dosing in intranasal Covid-19 drug study
AIM ImmunoTech has dosed the first healthy participants in a Phase I clinical study of its Ampligen drug as a…